Health ❯Healthcare

Weight Management

Health Impact on Family GLP-1 Agonists Substance Use Football Metabolic Health Clinical Studies Ophthalmology Dental Issues Oral Health Chronic Conditions

Eli Lilly’s Oral GLP-1 Pill Matches Injectables, Eyes Approval by Year-End

Phase 3 data recorded an average 7.9% weight loss alongside blood sugar reductions up to 1.6% with side effects akin to injectables.

Stories older than 24h

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Oxford Study Reveals Rapid Weight Regain After Stopping GLP-1 Drugs

Mum Regrets £10k Weight-Loss Surgery After Life-Threatening Complications

WeightWatchers Files for Bankruptcy as GLP-1 Weight-Loss Drugs Reshape Industry

Weight Management Revolution: GLP-1 Drugs Dominate as Pills Emerge

WeightWatchers Files for Chapter 11 Bankruptcy to Restructure $1.15 Billion Debt

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

GLP-1 Drugs Like Ozempic Show Promise in Reducing Cravings for Alcohol and Cocaine

UK Tightens Rules for Online Prescriptions of Weight-Loss Drugs

Hims & Hers Debuts Super Bowl Ad Advocating for Affordable Weight-Loss Drugs

Allurion Technologies Stock Surges Following New Obesity Treatment Study Announcement